NIZBRO-200 SR Tablets
Description
ACEBROPHYLLINE 200 MG
Packing: -10X10
M.R.P: - 1420
ACEBROPHYLLINE HAS 3 ACTIONS NAMELY BRONCHODILATION, MUCOREGULATION & ANTI-INFLAMMATORY ACTION. PHARMACOLOGY A.) PHARMACODYNAMICS: Acebrophylline inhibits intracellular phosphodiesterase associated significantly reduce the airway inflammation and obstruction in chronic stages. Acebrophylline increases the synthesis and release of alveolar surfactant, resulting in triple action: mucoregulation, stimulation of bronchoalveolar clearance, and anti-inflammatory-antireactive effect. In patients with chronic obstructive bronchitis, given the drug for 10-20 days, there was a good reduction in expectorate Viscosity.with cAMP levels and facilitates bronchial muscles relaxation. Acebrophylline selectively inhibits phosphatidylcholine and phospholipase A, TNF-alpha and leukotrienes. Inhibition of such pro-inflammatory mediators can.
B.) PHARMACOKINETICS:
• Absorption: – 200mg oral acebrophylline, the two components of the molecule ambroxol and theophylline-7-acetic acid are released in the stomach and absorbed in the intestine, reaching optimal concentrations of ambroxol within 2 hrs and of theophylline-7-acetic acid after 1 hr.
• Half-Life: – The plasma half life varies from 4 to 9 hrs after oral administration. • Metabolism: – The drug is metabolized in the liver and eliminated renally. Indications Treatment of adult patients with COPD and bronchial asthma.
Tags
Pharmaceutical Tablets
Packing
Share Product
Related Products
Post your Requirement
You are looking for?
Requirement Emergency
Call-Time Preference